| Price | 127.00p on 27-03-2025 at 17:30:01 |
|---|---|
| Change | 1.00p 0.79% |
| Buy | 130.00p |
| Sell | 124.00p |
| Buy / Sell DXRX Shares | |
| Last Trade: | Buy 25,000.00 at 126.8095p |
| Day's Volume: | 0 |
| Last Close: | 127.00p |
| Open: | 127.00p |
| ISIN: | GB00BJQTGV64 |
| Day's Range | 127.00p - 127.00p |
| 52wk Range: | 95.00p - 151.00p |
| Market Capitalisation: | £107m |
| VWAP: | 0.00p |
| Shares in Issue: | 85m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Diaceutics (DXRX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 25,000 | 126.8095p | Suspected BUY Trade |
16:39:31 - 26-Mar-25 |
| Buy* | 1 | 126.00p | SI Trade |
16:35:04 - 26-Mar-25 |
| Buy* | 6 | 126.00p | Suspected BUY Trade |
16:35:04 - 26-Mar-25 |
| Sell* | 1,163 | 124.20p | Ordinary |
15:32:46 - 26-Mar-25 |
| Buy* | 3,000 | 128.00p | Ordinary |
08:18:40 - 26-Mar-25 |
| Unknown* | 25,000 | 127.00p | Negotiated Trade |
08:11:56 - 26-Mar-25 |
| Unknown* | 25,000 | 127.00p | Ordinary |
08:11:35 - 26-Mar-25 |
| Buy* | 2,170 | 128.44p | Ordinary |
08:01:57 - 26-Mar-25 |
| Buy* | 962 | 128.44p | Ordinary |
08:01:05 - 26-Mar-25 |
| Buy* | 18,000 | 125.3118p | Suspected BUY Trade |
16:43:44 - 25-Mar-25 |
Diaceutics (DXRX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Mar 2025 7:00 am | RNS | PMx Promotional Partner Contract Enhancement |
| 6th Mar 2025 3:16 pm | RNS | Holding(s) in Company |
| 3rd Mar 2025 3:00 pm | RNS | PDMR Shareholding/Share Incentive Plan and TVR |
| 31st Jan 2025 9:13 am | RNS | Purchase of Shares and PDMR Shareholding |
| 30th Jan 2025 11:27 am | RNS | PDMR Shareholding/Share Incentive Plan |
| 28th Jan 2025 7:00 am | RNS | FY 2024 Trading Update - Strong Revenue Growth |
| 14th Jan 2025 7:00 am | RNS | Diaceutics Opens US Headquarters |
| 8th Jan 2025 7:00 am | RNS | New Service Launched & First Contract Signed |
| 3rd Jan 2025 3:39 pm | RNS | PDMR Dealings & Total Voting Rights |
| 19th Dec 2024 8:09 am | RNS | Holding(s) in Company |
